IP Library Granted Patent US 12,508,371
Granted Patent B2
US 12,508,371 · App. 17/594,530 · Granted Dec 30, 2025

Injection monitoring module

Inventors: Alain Marcoz (Issoire, FR); Lionel Aldon (Issoire, FR)
A61M5/3155A61M5/31553A61M5/31568A61M5/3158A61M2205/0272A61M2205/3317A61M2205/50A61M2205/8206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,508,371
App. No.
17/594,530
Granted
Dec 30, 2025
Kind
B2
Abstract

An injection monitoring module adapted and configured to be removably attached to a proximal extremity of an injection pen system for delivery of a drug. The monitoring module comprises a hollow main body adapted and configured to be coaxially mounted on, and engage in co-rotation with, a dose setting wheel of the pen injection system, and a central longitudinal bore with a proximal extremity and a distal extremity and an injection monitoring system located in the bore at a proximal extremity thereof. An injection monitoring system is movable within the bore along a central longitudinal axis thereof from a first monitoring position in which the injection monitoring system is not in abutting contact with a proximal surface of an injection activator of the injection pen system, to a second monitoring position in which the injection monitoring system is in abutting contact with the proximal surface of the injection activator.

Claims (30)

1 . Injection monitoring module adapted and configured to be removably attached to a proximal extremity of an injection pen system for delivery of a drug, the injection pen system being equipped with a proximally located dose setting wheel and injection activator, the dose setting wheel being rotatable about a central longitudinal axis of the pen injection system for dose setting and during injection, wherein the injection monitoring module comprises:

a hollow main body adapted and configured to be coaxially mounted on, and engage in co-rotation with, the dose setting wheel at the proximal extremity of the pen injection system;

the hollow main body comprising a central longitudinal bore with a proximal extremity and a distal extremity; and

an injection monitoring system located within the central longitudinal bore of the main body at the proximal extremity thereof and extending beyond said proximal extremity along said longitudinal axis in a proximal direction, said injection monitoring system includes a magnetic field producing means which is seated immovably within the bore of the hollow main body and a magnetic field sensor, located on the central longitudinal axis, wherein the magnetic field sensor is movable within the central longitudinal bore from a first monitoring position in which the injection monitoring system is not in abutting contact with a proximal surface of the injection activator, to a second monitoring position in which the injection monitoring system is in abutting contact with a proximal surface of the injection activator; and

wherein the injection monitoring system further comprises a rotational movement measurement means, configured to detect and/or measure a user-induced rotational movement of the injection monitoring system, upon activation of the injection activator from the first monitoring position to the second monitoring position, and

wherein the injection monitoring system further comprises a microcontroller configured to determine an injected dose in accordance with changes in magnetic field detected by the magnetic field sensor when said magnetic field sensor moves from the first monitoring position to the second monitoring position, and in accordance with any measurements made by the rotational movement measurement means.

2 . Injection monitoring module according to claim 1 , wherein the injection monitoring system is mounted within a selectively engageable, and respectively disengageable, clutch assembly.

3 . Injection monitoring module according to claim 1 , wherein said magnetic field producing means is seated immovably within the bore of the hollow main body and around the central longitudinal axis.

4 . Injection monitoring module according to claim 3 wherein said magnetic field producing means comprising two diametrically aligned single dipole magnets seated immovably within the bore of the hollow main body and around the central longitudinal axis.

5 . Injection monitoring module according to claim 1 , wherein the injection monitoring system comprises an electronic component board, and wherein said magnetic field sensor and said microcontroller are electrically connected to the electronic component board.

6 . Injection monitoring module according to claim 1 , wherein said magnetic field sensor is located on a proximal face of a electronic component board.

7 . Injection monitoring module according to claim 1 , comprising a clutch assembly which comprises a first, distal body and a second, proximal body.

8 . Injection monitoring module according to claim 7 , wherein said clutch assembly further comprises a biasing member located between a first, distal body and a second, proximal body.

9 . Injection monitoring module according to claim 7 , wherein said second, proximal body of said clutch assembly is an electronic component board holder body, and an electronic component board is located within the component board holder body.

10 . Injection monitoring module according to claim 7 , wherein a first distal body of said clutch assembly is a power supply holder body.

11 . Injection monitoring module according to claim 7 , wherein said clutch assembly comprising a first, distal body, and a second, proximal body are directly connected together around and along the central longitudinal axis.

12 . Injection monitoring module according to claim 7 , wherein said clutch assembly comprising a first, distal body is located distally of said magnetic field producing means.

13 . Injection monitoring module according to claim 7 , wherein a first, distal body of said clutch assembly is located proximally of said magnetic field producing means.

14 . Injection monitoring module according to claim 11 , wherein said second, proximal body of said clutch assembly is located proximally of said magnetic field producing means.

15 . Injection monitoring module according to claim 11 , wherein said biasing member is located proximally of said magnetic field producing means and distally of said second, proximal body of said clutch assembly.

16 . Injection monitoring module according to claim 1 , wherein said magnetic field producing means is located within the main hollow body of the injection monitoring module, adjacent the activator button of the pen injection system.

17 . Injection monitoring module according to claim 7 , wherein a first distal body and a second proximal body of said clutch assembly are located proximally of said magnetic field production means in the first monitoring position, and the first distal body is located substantially at the level of the magnetic field production means in the second monitoring position.

18 . Process for calculating an actual amount of drug ejected or injected from a pen injection system comprising:

mounting an injection monitoring module, comprising an injection monitoring system according to claim 1 , to a proximal extremity of an injection pen system for delivery of a drug, the injection pen system being equipped with a proximally located dose setting wheel and an injection activator, the dose setting wheel being rotatable about a central longitudinal axis of the pen injection system for dose setting and during injection;

setting a dose via rotation of the dose setting wheel;

activating the injection activator to effect an injection;

determining, an injected dose in accordance with changes in magnetic field detected by the magnetic field sensor during a translational movement of the injection monitoring system caused by activation of the injection activator, from a first monitoring position in which the injection monitoring system is not in abutting contact with a proximal surface of the injection activator, to a second monitoring position in which the injection monitoring system is in abutting contact with a proximal surface of the injection activator;

detecting a user-induced rotational movement of the injection monitoring system with a rotational movement measurement means configured to, upon activation of the injection activator from the first monitoring position in which the injection monitoring system is not in abutting contact with a proximal surface of the injection activator, to the second monitoring position in which the injection monitoring system is in abutting contact with the proximal surface of the injection activator, measure any such user-induced rotational movement of the injection monitoring system; and

determining a corrected injected dose from translational movement of the injection monitoring system caused by activation of the injection activator, from the first monitoring position to the second monitoring position, wherein the determining of said corrected dose takes into account any measurements made by the rotational movement measurement means.

19 . The Injection monitoring module of claim 1 , wherein said microcontroller is configured to determine changes in magnetic field caused by said user-induced rotational movement.

Assignments (2)
CHANGE OF NAME Recorded Dec 2, 2025
From: BIOCORP PRODUCTION S.A
To: BIOCORP PRODUCTION
Reel/Frame 074101/0799 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2021
From: MARCOZ, ALAIN; ALDON, LIONEL
To: BIOCORP PRODUCTION S.A.
Reel/Frame 057906/0452 →
Priority Claims (1)
WO PCT/IB2019/000493 · Apr 26, 2019 · international
Continuity (1)
Related Publication 20220088317A1 · Mar 24, 2022
References Cited (25)
US 9649448B2 · Madsen · 2017 [cited by examiner]
US 11020533B2 · Erbstein · 2021 [cited by examiner]
US 20020143288A1 · Larsen et al. · 2002 [cited by applicant]
US 20110313395A1 · Krulevitch et al. · 2011 [cited by applicant]
US 20140276583A1 · Chen et al. · 2014 [cited by applicant]
US 20150246179A1 · Zur · 2015 [cited by applicant]
US 20160015903A1 · Madsen et al. · 2016 [cited by applicant]
US 20170189625A1 · Cirillo · 2017 [cited by examiner]
US 20180154086A1 · Toporek et al. · 2018 [cited by applicant]
US 20200188601A1 · Jung et al. · 2020 [cited by applicant]
CN 1684729A · 2005 [cited by applicant]
CN 202105264U · 2012 [cited by applicant]
CN 106714878B · 2020 [cited by applicant]
CN 107106785B · 2021 [cited by applicant]
CN 107921217B · 2022 [cited by applicant]
EP 2644217A1 · 2012 [cited by applicant]
EP 3545995A1 · 2018 [cited by applicant]
JP 2016514249A · 2016 [cited by applicant]
JP 2018517502A · 2018 [cited by applicant]
WO 2014128156A1 · 2014 [cited by applicant]
WO 2017013463A1 · 2017 [cited by applicant]
WO 2017013464A1 · 2017 [cited by applicant]
WO 2018013419A1 · 2018 [cited by applicant]
WO 2019001919A1 · 2019 [cited by applicant]
WO WO2019057911A1 · 2019 [cited by examiner]